DEF: CSLM Seeks Extension for Fusemachines AI Merger

Sentiment:

Definitive Proxy Statement


CSLM Acquisition Corp. is seeking shareholder approval to extend its business combination deadline until December 18, 2025, to complete its merger with AI provider Fusemachines Inc.

Delay expectedThe company is seeking to extend its business combination deadline from October 18, 2025, to December 18, 2025, citing insufficient time to complete the Proposed Business Combination and hold a shareholder vote.This is a continuation of previous extensions, with prior deadlines being October 18, 2024, and July 18, 2025.The company failed to consummate its business combination by January 12, 2025 (36 months post-IPO), which led to its securities being delisted from Nasdaq.
Capital raiseThe Sponsor will provide bi-weekly contributions (loans) of the lesser of $0.02 per non-redeemed share or $15,000 for each semi-monthly extension period, starting October 18, 2025, if the Extension Proposal is approved. These loans are repayable upon consummation of the business combination.The Sponsor or an affiliate has issued working capital loans to the Company up to $4,000,000. These loans will be forgiven if the business combination is not consummated, except to the extent of funds held outside the Trust Account.

Summary

  • CSLM Acquisition Corp. (SPAC) is holding an Extraordinary General Meeting on October 14, 2025, to vote on three proposals.
  • The primary proposal is to amend the Company's Existing Charter to extend the deadline for completing its initial business combination from October 18, 2025 (Current Termination Date) to December 18, 2025 (Extended Date), on a semi-monthly basis.
  • A related proposal seeks to amend the Investment Management Trust Agreement to allow for this extension of the Combination Period.
  • An Adjournment Proposal will also be presented, if necessary, to permit further solicitation of proxies for the other two proposals.
  • The purpose of the extension is to provide more time to complete the proposed business combination with Fusemachines Inc., a global provider of enterprise Artificial Intelligence (AI) products and solutions.
  • Under the Merger Agreement, Fusemachines securityholders will receive CSLM Common Shares equivalent to $200,000,000 divided by $10.00.
  • If the Extension Proposal is approved, the Sponsor (Consilium Acquisition Sponsor I, LLC) will contribute the lesser of $0.02 per non-redeemed share or $15,000 every two weeks as a loan to the Company for each semi-monthly extension period, starting October 18, 2025.
  • Public shareholders have the right to redeem their shares for cash at approximately $13.64 per share (based on the Trust Account balance as of October 3, 2025) if the extension is approved.
  • CSLM's securities were suspended from trading on Nasdaq on January 22, 2025, due to failure to consummate a business combination by January 12, 2025, and now trade on the OTC Markets Group, Inc. Pink Open Market.

Sentiment

Score: 4

Explanation: The filing indicates ongoing challenges for the SPAC, including multiple extensions, significant redemptions, and a Nasdaq delisting. While a target (Fusemachines) has been identified, the need for another extension and the associated risks suggest a precarious situation, despite the board's recommendation to approve the extension. The high insider ownership and their voting power are notable, but the overall situation remains high-risk for public shareholders.

Positives

  • The company has identified a specific target, Fusemachines Inc., an AI products and solutions provider, which is described as a compelling opportunity.
  • The Sponsor is committed to providing bi-weekly contributions (loans) of the lesser of $0.02 per non-redeemed share or $15,000 to fund the extension, demonstrating continued support for the business combination.
  • Public shareholders retain redemption rights, offering an exit option at a per-share price of approximately $13.64 (as of October 3, 2025) if the extension is approved.

Negatives

  • The company has failed to complete its business combination by previous deadlines, leading to its delisting from Nasdaq and trading on the OTC Markets.
  • Significant redemptions have occurred in connection with prior extension votes, reducing the Trust Account balance and increasing the percentage interest of insider shares.
  • If the proposals are not approved or the business combination is not completed by the extended date, the company will be forced to liquidate, rendering Private Warrants held by the Sponsor worthless.
  • Public shareholders face the risk of losing their investment opportunity and potential future gains if liquidation occurs.
  • The market price of CSLM's Public Shares on OTC ($14.00 as of October 3, 2025) is only slightly above the redemption price ($13.64), and there is no assurance of sufficient liquidity to sell shares in the open market.

Risks

  • The company may not be able to complete the Proposed Business Combination by the Extended Date, leading to liquidation and the loss of investment for shareholders.
  • Shareholders could potentially be liable for claims of creditors to the extent of distributions received if the company enters an insolvent liquidation.
  • There is no guarantee that vendors and service providers will waive their rights to claims against the Trust Account.
  • The company risks being deemed an investment company under the Investment Company Act of 1940, which would force liquidation.
  • The Proposed Business Combination with a U.S. target company (Fusemachines) may be subject to U.S. foreign investment regulations and review by CFIUS, potentially blocking or delaying the merger.
  • The process of government review (e.g., CFIUS) could be lengthy, and the company has limited time to complete its initial business combination.
  • If the company liquidates, public shareholders may only receive approximately $13.64 per Ordinary Share, and warrants and rights will expire worthless.
  • The removal of funds from the Trust Account due to redemptions will reduce the amount remaining and increase the percentage interest of shares held by officers, directors, and their affiliates.
  • There may not be sufficient liquidity in the OTC market for shareholders to sell their Public Shares, even if the market price is higher than the redemption price.

Future Outlook

The company intends to continue its efforts to consummate the Proposed Business Combination with Fusemachines Inc. until the Extended Date of December 18, 2025, if the extension proposals are approved. If the board determines it will not be able to complete the combination by the Extended Date, or if the proposals are not approved, the company will cease operations and liquidate.

Management Comments

  • "The Company believes the target business is a compelling opportunity for the Company's initial business combination and is currently in the process of completing an initial business combination."
  • "Our board of directors currently believes that there will not be sufficient time before the Current Termination Date to complete the Proposed Business Combination and hold a general meeting at which to conduct a vote for shareholder approval of the Proposed Business Combination."
  • "Accordingly, our board of directors has determined it is in the best interests of the Company and our shareholders to extend the termination date from the Current Termination Date to the Extended Date."
  • "The Board unanimously recommends that you vote FOR the Extension Proposal, FOR the Trust Amendment Proposal, and FOR the Adjournment Proposal. The Board expresses no opinion as to whether you should redeem your Public Shares."

Industry Context

CSLM Acquisition Corp. is a Special Purpose Acquisition Company (SPAC) operating in an environment where SPACs face increasing pressure to complete mergers within their mandated timelines. The target, Fusemachines Inc., is an Artificial Intelligence (AI) products and solutions provider, aligning CSLM with the high-growth AI industry. However, CSLM's history of multiple extensions, significant shareholder redemptions, and delisting from Nasdaq to the OTC market reflects broader challenges and investor skepticism prevalent in the SPAC market, particularly for those struggling to finalize deals.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Charter AmendmentProposed amendment to the Company's Existing Charter to extend the business combination deadline from October 18, 2025, to December 18, 2025, on a semi-monthly basis.Upon shareholder approval and filing with the Registrar of Companies of the Cayman Islands.Provides additional time for the company to complete its proposed merger, but also prolongs uncertainty and may lead to further shareholder redemptions.
Trust Agreement AmendmentProposed amendment to the Investment Management Trust Agreement to allow the Company to extend the Combination Period on a semi-monthly basis until December 18, 2025.Upon shareholder approval and execution of the amendment.Aligns the terms of the trust account with the proposed extended timeline, which is critical for the company's continued operation and pursuit of the business combination.

Related Party Transactions

  • The Sponsor (Consilium Acquisition Sponsor I, LLC) and its affiliates (including Charles Cassel and Jonathan Binder) beneficially own 4,743,750 Ordinary Shares (acquired for $25,000) and 7,942,500 Private Warrants (acquired for $7,942,500), which will become worthless if the business combination is not completed.
  • The Sponsor has agreed to waive its rights to liquidating distributions from the trust account in respect of any Sponsor Shares.
  • The Sponsor will contribute the lesser of $0.02 per non-redeemed share or $15,000 every two weeks as a loan to the Company for extensions, repayable upon business combination consummation.
  • The Sponsor or an affiliate has issued working capital loans up to $4,000,000 to the Company, which will be forgiven if the business combination is not consummated (except for funds outside the Trust Account).
  • The Company's officers and directors are entitled to reimbursement of out-of-pocket expenses, but will not have claims against the Trust Account for such reimbursement if the business combination is not completed.

Stakeholder Impact

  • **Shareholders (Public)**: Face a decision to redeem shares at approximately $13.64 per share or hold for potential upside from the Fusemachines merger. They bear the risk of liquidation if the merger fails and the illiquidity of shares on the OTC market.
  • **Shareholders (Sponsor/Insiders)**: Have a significant financial incentive to complete the business combination, as their substantial holdings of founder shares and private warrants would be worthless upon liquidation. They are actively supporting the extension through loans.
  • **Fusemachines Inc.** (Target Company): The completion of its merger with CSLM is contingent on CSLM securing this extension. A failure to extend could jeopardize the merger.
  • **Creditors**: In the event of liquidation, creditors take priority over public shareholders, and there is a risk that claims may not be fully assessed or waived against the Trust Account.

Next Steps

  • Hold an Extraordinary General Meeting on October 14, 2025, to vote on the Extension Proposal, Trust Amendment Proposal, and Adjournment Proposal.
  • If the Extension Proposal and Trust Amendment Proposal are approved, the Company will file amendments to its Existing Charter and Trust Agreement.
  • Continue efforts to consummate the Proposed Business Combination with Fusemachines Inc. by the new Extended Date of December 18, 2025.
  • If the proposals are not approved or the business combination fails by the deadline, the company will cease operations and liquidate.

Key Dates

DateDescription
January 12, 2022Date of the Investment Management Trust Agreement.
January 18, 2022Consummation date of the Company's Initial Public Offering (IPO).
July 13, 2023Shareholders approved an amendment to extend the business combination period until October 18, 2024; 14,202,813 Public Shares were redeemed.
January 22, 2024Merger Agreement entered into with Fusemachines Inc.
August 18, 2024Shareholders approved an amendment to the Trust Agreement to extend the business combination period until July 18, 2025; 3,399,500 Class A Ordinary Shares were redeemed.
January 12, 202536 months after the effective date of the IPO; business combination was not consummated by this date.
January 15, 2025CSLM received a notice from Nasdaq regarding non-compliance and potential delisting.
January 22, 2025CSLM's securities were suspended from trading on Nasdaq and began trading on OTC Markets.
July 14, 2025Shareholders voted to extend the time to complete the Business Combination; 371,545 Class A Shares were tendered for redemption.
July 28, 2025Extraordinary Meeting held to approve the Business Combination; 99,187 Class A Shares were tendered for redemption.
September 26, 2025Record date for determining shareholders entitled to vote at the General Meeting.
October 3, 2025Date of the proxy statement.
October 6, 2025Deadline to request documents for timely delivery in advance of the General Meeting.
October 10, 2025Deadline to tender shares for redemption (two business days prior to the General Meeting).
October 14, 2025Date of the Extraordinary General Meeting.
October 18, 2025Current Termination Date for the business combination, which the company proposes to extend from. Also, the proposed start date for Sponsor contributions if the extension is approved.
December 18, 2025Proposed Extended Date for completing the business combination.

Recommendation

hold

The company is at a critical juncture, seeking another extension to complete its merger with an AI company. While the target (Fusemachines) is in a high-growth sector, the SPAC's history of multiple extensions, significant redemptions, and Nasdaq delisting indicates considerable operational challenges and investor skepticism. The current redemption price is slightly below the OTC market price, offering a potential exit for some, but the illiquidity on OTC is a concern. The Sponsor's continued financial support for extensions is a positive, but the overall situation remains high-risk. A 'hold' recommendation acknowledges the potential upside if the merger with Fusemachines is successful, given the AI sector's growth, but also recognizes the substantial risks of further delays or liquidation. Investors should monitor the vote outcome and the progress of the business combination closely.

Keywords

SPAC, CSLM Acquisition Corp, Fusemachines Inc, Artificial Intelligence, AI, Merger, Business Combination, Extension, Proxy Statement, SEC Filing, Trust Account, Redemption Rights, Nasdaq Delisting, OTC Markets, Corporate Governance, Shareholder Vote

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.